Deep Sequencing of Crohn's Disease Lamina Propria Phagocytes Identifies Pathobionts and Correlates With

Gillian E Jacobsen1,2,3, Eddy E Gonzalez3, Payton Mendygral3

  • 1Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL, USA.

Inflammatory Bowel Diseases
|February 14, 2025
PubMed
Abstract

Insights

Phagocytes in Crohn's disease (CD) ileum harbor specific bacteria like E. coli, which show increased inflammatory gene expression in the host. These findings reveal potential pathobionts and immune targets for CD therapies.

Area of Science:

  • Gastroenterology
  • Immunology
  • Microbiome Research

Background:

  • Crohn's disease (CD) involves an inflammatory response to gut microbiota.
  • Macrophages and dendritic cells are key players in CD inflammation.
  • Specific gut microbes are implicated in the pathogenesis of ileal CD.

Purpose of the Study:

  • To investigate the phagocyte-associated microbiome in CD using unbiased sequencing.
  • To identify potential pathobionts contributing to CD.
  • To understand the host immune response to these microbes.

Main Methods:

  • Collected ileal and colonic mucosal biopsies from CD patients and controls.
  • Isolated lamina propria phagocytes (CD11b+ cells) for deep RNA sequencing.
  • Performed microbiome taxonomic and metatranscriptomic profiling, confirmed in a second cohort.

Main Results:

  • Ileal phagocytes in CD showed higher abundances of Escherichia coli, Ruminococcus gnavus, and Enterocloster spp.
  • CD-associated microbes exhibited increased lipopolysaccharide (LPS) biosynthesis pathway expression.
  • Phagocytes with higher pathobiont burden displayed elevated pro-inflammatory and antimicrobial gene expression.

Conclusions:

  • Resident phagocytes in the lamina propria harbor bacterial strains acting as pathobionts in CD.
  • Findings illuminate the role of pathobionts and immune response in CD pathogenesis.
  • Identified potential new therapeutic targets for CD.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
166
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
122
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
380